124 related articles for article (PubMed ID: 11876533)
1. Urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) expression and activity during early embryo development in the cow.
Whiteside EJ; Kan M; Jackson MM; Thompson JG; McNaughton C; Herington AC; Harvey MB
Anat Embryol (Berl); 2001 Dec; 204(6):477-83. PubMed ID: 11876533
[TBL] [Abstract][Full Text] [Related]
2. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor.
Harvey MB; Leco KJ; Arcellana-Panlilio MY; Zhang X; Edwards DR; Schultz GA
Development; 1995 Apr; 121(4):1005-14. PubMed ID: 7743917
[TBL] [Abstract][Full Text] [Related]
3. Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.
Martínez-Hernández MG; Baiza-Gutman LA; Castillo-Trápala A; Armant DR
Reproduction; 2011 Feb; 141(2):227-39. PubMed ID: 21075828
[TBL] [Abstract][Full Text] [Related]
4. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasminogen activator genes and enzymatic activities in rat preimplantation embryos.
Zhang X; Kidder GM; Zhang C; Khamsi F; Armstrong DT
J Reprod Fertil; 1994 May; 101(1):235-40. PubMed ID: 8064688
[TBL] [Abstract][Full Text] [Related]
7. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig.
Menino AR; Hogan A; Schultz GA; Novak S; Dixon W; Foxcroft GH
Dev Genet; 1997; 21(1):68-74. PubMed ID: 9291582
[TBL] [Abstract][Full Text] [Related]
8. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
9. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
10. Novel laminin 5 gamma 2-chain fragments potentiating the limbal epithelial cell outgrowth on amniotic membrane.
Cheng CY; Sun CC; Yu WH; Hsieh HL; Ma DH; Pang JH; Yang CM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4631-9. PubMed ID: 19420329
[TBL] [Abstract][Full Text] [Related]
11. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
Nalbandian A; Djakiew D
Clin Exp Metastasis; 2006; 23(2):107-16. PubMed ID: 16912916
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of proteases in co-cultures.
Paduch R; Kandefer-Szerszeń M
Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
[TBL] [Abstract][Full Text] [Related]
13. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
[TBL] [Abstract][Full Text] [Related]
14. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.
El Fahime E; Mills P; Lafreniere JF; Torrente Y; Tremblay JP
Exp Cell Res; 2002 Nov; 280(2):169-78. PubMed ID: 12413883
[TBL] [Abstract][Full Text] [Related]
15. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.
Castelló R; Estellés A; Vázquez C; Falcó C; España F; Almenar SM; Fuster C; Aznar J
Clin Chem; 2002 Aug; 48(8):1288-95. PubMed ID: 12142386
[TBL] [Abstract][Full Text] [Related]
16. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle.
Gabler C; Killian GJ; Einspanier R
Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336
[TBL] [Abstract][Full Text] [Related]
18. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9.
Shin SM; Cho KS; Choi MS; Lee SH; Han SH; Kang YS; Kim HJ; Cheong JH; Shin CY; Ko KH
Neurochem Res; 2010 Jul; 35(7):976-85. PubMed ID: 20177776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
